Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
0.3
Year-on-year change (revenue, %)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationSecond quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥253.1 100 million-0.3%
Ordinary income¥24.5 100 million+3.9%
Net income¥15 100 million+1.5%
Gross Profit Margin23.3 % / percentage points
Full-year earnings forecast
Net Sales
¥514.3 100 million
Gross profit
¥121.7 100 million
Ordinary income
¥46.6 100 million
Net income
¥27.7 100 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net SalesProvided (chart)
Ordinary incomeProvided (chart)
Net incomeProvided (chart)
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressing steadilyBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Factors Increasing Operating Profit
- Higher staffing fees and increased revenue
- Sale of unprofitable overseas operations and lower cost of sales
Factors Decreasing Operating Profit
- Lower domestic orders and decreased revenue
- Higher SG&A expenses due to depreciation expenses for the new headquarters and temporary costs associated with relocating offices
New initiatives
- Increase staffing fees and compensation for temporary staff
- Strengthening of the sales and dedicated staffing structures
- Revamp the recruitment structure for permanent-employee staffing and use social media for recruitment
- Expand adoption of Doco 1
- Use internally developed tools and AI in CRO operations
- Revise the dividend payout ratio target to 65%
Key KPIsA metric the company considers important as a management benchmark.
- Number of employees990 People
- Temporary staff and other personnel10,163 People
- Science-related staffing market size¥1,100 100 million
- Science-related staffing market share30 %
Segment results
Human resources services business
Net SalesNot disclosed (chart)
Revenue growth year on year0.9
Operating profitNot disclosed (chart)
Operating profit growth year on year6.8
CRO Business
Net SalesNot disclosed (chart)
Revenue growth year on year-7.9
Operating profitNot disclosed (chart)
Operating profit growth year on year12.2
Market Size / Share
Scientific-sector staffing market1,100
Market size unit¥100 million
Market share30
Market share unit%
Number of employees
Number of Employees990 employees; 10,163 temporary staff and others
Hiring planContinue recruiting new graduates for region-specific positions
Payout ratio
65% benchmarkAcquisition of treasury shares
Policy is generally not to conduct share buybacks| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | Second quarter of the fiscal year ending March 2027 |
| Net Sales | ¥253.1 100 million (YoY -0.3%) |
| Ordinary income | ¥24.5 100 million (YoY +3.9%) |
| Net income | ¥15 100 million (YoY +1.5%) |
| Gross Profit Margin | 23.3 % / percentage points |
| Full-year earnings forecast | Net Sales ¥514.3 100 million / Gross profit ¥121.7 100 million / Ordinary income ¥46.6 100 million / Net income ¥27.7 100 million |
| Progress against full-year forecast | Net Sales Provided (chart) / Ordinary income Provided (chart) / Net income Provided (chart) |
| Self-assessment against the plan | Progressing steadily |
| Segment results | Human resources services business Net Sales Not disclosed (chart) / Revenue growth year on year 0.9 / Operating profit Not disclosed (chart) / Operating profit growth year on year 6.8 / CRO Business Net Sales Not disclosed (chart) / Revenue growth year on year -7.9 / Operating profit Not disclosed (chart) / Operating profit growth year on year 12.2 |
| Breakdown of Factors Affecting the Change | Factors Increasing Operating Profit Higher staffing fees and increased revenue, Sale of unprofitable overseas operations and lower cost of sales / Factors Decreasing Operating Profit Lower domestic orders and decreased revenue, Higher SG&A expenses due to depreciation expenses for the new headquarters and temporary costs associated with relocating offices |
| Key KPIs | Number of employees 990 People, Temporary staff and other personnel 10,163 People, Science-related staffing market size ¥1,100 100 million, Science-related staffing market share 30 % |
| Number of employees | Number of Employees 990 employees; 10,163 temporary staff and others / Change during the period Not disclosed / Hiring plan Continue recruiting new graduates for region-specific positions |
| Payout ratio | 65% benchmark |
| Acquisition of treasury shares | Policy is generally not to conduct share buybacks |
| Market Size / Share | Market Size 1,100 / Market size unit ¥100 million / Market share 30 / Market share unit % / Subject Scientific-sector staffing market |
| New initiatives | Increase staffing fees and compensation for temporary staff, Strengthening of the sales and dedicated staffing structures, Revamp the recruitment structure for permanent-employee staffing and use social media for recruitment, Expand adoption of Doco 1, Use internally developed tools and AI in CRO operations, Revise the dividend payout ratio target to 65% |
Items this document does not state (14)
Operating profitOperating profit marginSelling, general and administrative expensesResults for the three months of the current quarterUnit price and quantity metricsNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsFinancial targetsAnnual DividendCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue declined due to lower revenue in the CRO business. Gross profit increased due to higher staffing fees and cost controls in the CRO business, while ordinary profit and net income increased as a result of higher gross profit. The factors behind the CRO business's revenue decline included lower domestic order volumes and the impact of selling unprofitable overseas operations.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.